Gameto
PrivateLast Round
Series C
Aug 12, 2025
Est. Valuation
$243M
Total Funding Raised
$127M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gameto is a biotechnology company that develops cell engineering platforms to create novel treatments for women's reproductive health, including infertility and ovarian aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gameto Comparables
Compare Gameto with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lavima Fertility | 84% | |
| Conception | 78% | |
| Granata Bio | 76% |
Gameto Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 12, 2025 | ||||
| Grant | Oct 23, 2024 | ||||
| Series B | May 29, 2024 | ||||
| Series A Extension | Sep 14, 2022 | ||||
| Series A | Jan 10, 2022 | ||||
Seed | Mar 1, 2020 |
Key People
Founding team and executive leadership
Gameto Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B |
| Future Ventures | Series B, Series C, Series A Extension, Series A |
| Khosla Ventures | Series C |
| Pontiva Healthcare Partners | Series C |
| Gaingels | Series A Extension |
| Portfolia | Series C |
| Pags Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 35% MoM, reaching 6.4K.
- Apr 16, 2026
Monthly visitors increased 43% MoM, reaching 7.8K.
Gameto Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gameto's valuation, stock price, and market status.
Is Gameto a public or private company?
Gameto is a private company.
What is the current stock price of Gameto?
Gameto is a private company with no public stock price. No recent secondary market data is available.
How much is Gameto worth (valuation)?
Gameto's valuation is estimated at $250.0M based on funding round data.
Can I buy Gameto stock?
Gameto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gameto's last funding round?
Gameto's most recent funding round was Series C on August 12, 2025.
Who are the main investors in Gameto?
Key investors in Gameto include RA Capital Management, Future Ventures, Two Sigma Ventures, ARPA-H, Overwater Ventures.
Will Gameto IPO soon?
No public IPO plans have been announced for Gameto.
How can I track Gameto secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gameto's secondary market activity and sign up for updates.